AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
31 Jul 2009 04:30 PM
RNS
Director/PDMR Shareholding
30 Jul 2009 11:00 AM
RNS
Half Yearly Report - Part 3 o
30 Jul 2009 11:00 AM
RNS
Half Yearly Report - Part 2 o
30 Jul 2009 11:00 AM
RNS
Half Yearly Report - Part 1 o
29 Jul 2009 09:00 AM
RNS
Notice of Results
09 Jul 2009 02:06 PM
RNS
AZ terminates MAP agreement
02 Jul 2009 01:00 PM
PRN
Latest Guidance Issued by BTS/SIGN Supports use...
01 Jul 2009 05:34 PM
RNS
Director/PDMR Shareholding
01 Jul 2009 07:00 AM
RNS
IRESSA EU approval
30 Jun 2009 05:26 PM
RNS
Total Voting Rights
26 Jun 2009 07:00 AM
RNS
ONGLYZA CHMP positive opinion
25 Jun 2009 05:31 PM
PRN
ONGLYZA(TM) (saxagliptin) Receives Positive Opi...
11 Jun 2009 07:00 AM
RNS
FDA AdCom recommendation on S
04 Jun 2009 12:45 PM
RNS
CERTRIAD NDA
29 May 2009 02:39 PM
RNS
Total Voting Rights
29 May 2009 07:00 AM
RNS
Seroquel XR Regulatory update
27 May 2009 04:30 PM
RNS
Director/PDMR Shareholding
21 May 2009 09:30 AM
PRN
Budesonide/Formoterol Plus Tiotropium Improves ...
21 May 2009 07:00 AM
RNS
Pulmicort Respules Patent Lit
20 May 2009 04:30 PM
RNS
Director/PDMR Shareholding
11 May 2009 07:00 AM
RNS
BRILINTA PLATO
07 May 2009 04:30 PM
RNS
AGM Resolutions filed with UK
30 Apr 2009 05:56 PM
RNS
Result of AGM
30 Apr 2009 05:47 PM
RNS
Total Voting Rights
30 Apr 2009 11:00 AM
RNS
1st Quarter Results - Part 2
30 Apr 2009 11:00 AM
RNS
1st Quarter Results - Part 1
29 Apr 2009 09:00 AM
RNS
Notice of Results
23 Apr 2009 04:48 PM
RNS
IRESSA CHMP positive opinion
23 Apr 2009 01:00 PM
RNS
FDA extend timeline for Ongly
17 Apr 2009 07:00 AM
RNS
Pulmicort Respules TRO Apotex
09 Apr 2009 07:00 AM
RNS
Seroquel XR MDD and GAD Adcom
07 Apr 2009 07:00 AM
RNS
Pulmicort Apotex litigation
06 Apr 2009 07:00 AM
RNS
OTC divestment approval
06 Apr 2009 07:00 AM
RNS
Symbicort CRL
03 Apr 2009 06:10 PM
RNS
FDA AdCom materials posted
02 Apr 2009 03:00 PM
RNS
Director/PDMR Shareholding
02 Apr 2009 07:00 AM
RNS
Onglyza AdComm
01 Apr 2009 04:30 PM
RNS
Director/PDMR Shareholding
31 Mar 2009 04:30 PM
RNS
Total Voting Rights
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
30 Mar 2009 05:30 PM
RNS
Director/PDMR Shareholding
25 Mar 2009 04:30 PM
RNS
Director/PDMR Shareholding
25 Mar 2009 04:30 PM
RNS
Director/PDMR Shareholding
20 Mar 2009 04:30 PM
RNS
Annual Information Update
17 Mar 2009 06:02 PM
RNS
Filing of 20-F
04 Mar 2009 03:03 PM
RNS
Annual Report and Accounts
02 Mar 2009 07:00 AM
RNS
Symbicort COPD
27 Feb 2009 04:00 PM
RNS
Total Voting Rights
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings